inspiremd inc (NSPR:NYSE Amex)

Executive Profile*

Background*

Prof. Chaim Lotan, M.D., F.A.C.C, F.E.S.C serves as Chief Medical Officer of InspireMD, Inc. Prof. Lotan serves as Medical Director of Arineta Ltd. He is the Head of The Heart Institute of the Hadassah University Medical Center. He is the Principle investigator in many of the leading studies in interventional cardiology and coronary stents, with many publications in this field. He is Professor of Medicine in Cardiology at The Hebrew University, and in 2004 he established ... the Hadassah Cardiovascular Research Center. Prof. Lotan founded the Israeli Working Group for Interventional Cardiology in Israel and served as its Secretary General for 4 years. He has, in addition, participated in various research projects and initiated and directed many study protocols, and continues to do so; he is a consultant to several start-up companies. He is Course Co-Director of the international scientific congress Innovations in Cardiovascular Interventions' held in Israel. He serves as a Member of Advisory Board at InspireMD Ltd. He serves as a Director of Allium-Medical Solutions Ltd. He serves as Member of Medical Advisory Board of Angioscore, Inc. and Paieon, Inc. He serves as a Member of Scientific Board of MediGuide Ltd and SMT R&D Ltd. He serves as a Member of Scientific Advisory Board at Keystone Heart, Ltd. He serves as a Member of Advisory Board at InspireMD, Inc. He served as a Director of the Heart Institute Hadassah University Medical Center since September 2000. He served as Director of Elutex Ltd. He served as Director of Interventional Cardiology at Hadassah. He is the Chairman of the Ministry of Health Committee for Certification & Licensing of Coronary Stents in the Israel. As a prominent figure in the world of interventional cardiology, Prof. Lotan was invited as a faculty member and a much appreciated lecturer to many of the leading interventional meetings and is one of the leading directors of the yearly international meeting of "Innovation in Cardiovascular Intervention".

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NSPR:US	$2.60 USD	-0.05

COMPETITOR COMPENSATION